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B R I E F  R E P O R T
The Maternal and Paternal Effects on Clinically and 
Surgically Defined Osteoarthritis
Eirik Weldingh,1 Marianne Bakke Johnsen,2 Kåre Birger Hagen,3 Nina Østerås,4 May Arna Risberg,1 Bård Natvig,1 
Barbara Slatkowsky-Christensen,4 Anne Marie Fenstad,5 Ove Furnes,6 Lars Nordsletten,2 and 
Karin Magnusson7
Objective. It is currently unknown whether osteoarthritis (OA) is inherited mainly from the mother, father, or both. 
This study was undertaken to explore the effect of maternal and paternal factors on hip, knee, and hand OA in off-
spring.
Methods. Participants from the Musculoskeletal Pain in Ullensaker Study (MUST) (69% female; mean ± SD age 
64 ± 9 years) and a Norwegian OA twin study (Nor- Twin) (56% female; 49 ± 11 years) reported whether their mother 
and/or father had OA. Using a recurrence risk estimation approach, we calculated whether maternal and paternal OA 
increased the risk of 1) surgically defined hip and knee OA (i.e., total joint replacement) and 2) clinically defined hip, 
knee, and hand OA (i.e., the American College of Rheumatology criteria) using logistic regression. Relative risks (RRs) 
with 95% confidence intervals (95% CIs) were calculated.
Results. Maternal OA consistently increased the risk of offspring OA across different OA locations and severi-
ties. Having a mother with OA increased the risk of any OA in daughters (RR 1.13 [95% CI 1.02–1.25] in the MUST 
cohort; RR 1.44 [95% CI 1.05–1.97] in the Nor- Twin cohort) but not (or with less certainty) in sons (RR 1.16 [95% CI 
0.95–1.43] in the MUST cohort; RR 1.31 [95% CI 0.71–2.41] in the Nor- Twin cohort). Having a father with OA was 
less likely to increase the risk of any OA in daughters (RR 1.00 [95% CI 0.85–1.16] in the MUST cohort; RR 1.52 [95% 
CI 0.94–2.46] in the Nor- Twin cohort) and sons (RR 1.08 [95% CI 0.83–1.41] in the MUST cohort; RR 0.93 [95% CI 
0.35–2.48] in the Nor- Twin cohort).
Conclusion. OA in the mother increased the risk of surgically and clinically defined hip, knee, and hand OA in 
offspring, particularly in daughters. Our findings imply that heredity of OA may be linked to maternal genes and/or 
maternal- specific factors such as the fetal environment.
INTRODUCTION
The etiology of hip, knee, and hand osteoarthritis (OA) is 
multifactorial, with familial factors playing a major role in disease 
development. Several studies have consistently demonstrated 
a strong genetic contribution to hip and hand OA (1–3). For the 
knee joint, familial OA in any joint, as well as other risk factors, 
predicts the future risk of having knee arthroplasty due to OA 
and a diagnostic code of knee OA (4).
Previous studies of familial aggregation have largely focused 
on the estimation of the broad- sense heritability using twin and 
sibling designs (1,3,5). However, this heritability alone may not be 
informative in the clinical setting as it cannot predict disease risk 
associated with the presence of OA in a family member, such as 
in the father or mother. The maternal versus paternal effects on 
the risk of mild- to- severe OA of the hip, knee, and hand joints are 
also unclear. To our knowledge, there are no studies exploring 
whether OA is mainly inherited from the mother or the father.
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A parent- of- origin approach in OA risk estimation may pro-
vide information on where to search for genetic or fetal environ-
mental factors in future studies on the etiology of OA. Improved 
knowledge of familial risk (i.e., whether OA in the mother or 
father increases the risk of OA in male or female offspring) may 
also further improve total risk prediction in OA and facilitate 
disease prevention (4). We investigated maternal and paternal 
effects on moderate- to- severe definitions of hip, knee, and 
hand OA using a recurrence risk estimation approach. To allow 
interpretation of our findings in relation to the results of previous 
studies, these effects were compared to the sibling effect.
PATIENTS AND METHODS
Study subjects and data collection. Data were obtained 
from 2 population- based cohorts: 1) the Musculoskeletal Pain in 
Ullensaker Study (MUST), a cross- sectional study of 630 persons 
ages 40–79 years with self- reported OA who attended a clinical 
examination between 2010 and 2013 (6), and 2) the Norwegian 
OA twin study (Nor- Twin), a longitudinal study of a sub- cohort of 
7,175 persons (of a total of 18,058) ages 30–75 years in 1990 who 
responded to questionnaires between 1990 and 1998 (1). Informa-
tion on maternal, paternal, and sibling/twin OA was self- reported at 
baseline in both studies (a yes/no answer to the question, “Did your 
mother/father/sibling have OA?”). For the MUST cohort, data on 
clinically defined hip, knee, and hand OA and on total joint replace-
ment (TJR) due to OA in offspring were obtained at a clinical joint 
examination by an experienced rheumatologist (BSC). For the Nor- 
Twin cohort, data on surgically treated OA of the hips and knees 
were obtained through linkage (in 2015) to the Norwegian Arthro-
plasty Register (7), which includes >95% of all prosthesis surgeries 
in Norway with information on reason and date of surgery (since 
1987 and 1994 for hip and knee surgeries, respectively). Both the 
MUST and Nor- Twin studies were approved by the Regional Ethics 
Committee (Oslo, Norway).
Outcome measure definitions. Clinical OA of the hip, 
knee, and hand joints was defined according to the American 
College of Rheumatology (ACR) criteria (8–10) and based on a 
thorough examination of soft tissue swelling, bony enlargement, 
joint tenderness, and reduced joint mobility (6). Visible osteophyte 
presence on radiographs was also required for defining knee OA, 
whereas an erythrocyte sedimentation rate (ESR) of <20 mm/hour, 
joint space narrowing, and visible osteophyte presence on radio-
graphs was required for defining hip OA (6). We defined surgical 
OA as an individual having had TJR due to primary OA in the left 
or right hip or knee (at any date until the examination date for the 
MUST cohort and until 2015 for the Nor- Twin cohort) (1,6). Full data 
on surgery of the hand joints were lacking and thus not analyzed in 
the current study.
Statistical analysis. We calculated the relative risk (RR) of 
recurrence (with 95% confidence intervals [95% CIs]), which is a 
prospective measure of risk used for counseling. RR can be esti-
mated as the offspring’s risk of disease with the presence of dis-
ease in a sibling/parent divided by the offspring’s risk of disease 
without the presence of disease in a sibling/parent. We used logistic 
regression to estimate RR for the following OA outcomes: clinically 
defined hip, knee, and hand OA (MUST cohort only) and surgically 
defined hip and knee OA (MUST and Nor- Twin cohorts). We stud-
ied the 2 OA definitions as mutually exclusive groups to account for 
the fact that OA frequently presents as a generalized disease (11). 
Thus, as an example, people who had TJRs did not fulfill the ACR 
criteria for OA in other joints. Similarly, the control group without the 
OA definition in question was also free of any OA at any other site. 
In this manner, the control group was similar for all OA definitions in 
question, and thus similar for all analyses.
The relatives’ disease status included OA present in moth-
ers, fathers, and siblings. In the Nor- Twin study, offsprings’ siblings 
were either identical twins or fraternal twins of the same sex. In 
stratified analyses, we explored whether OA was mainly transmit-
ted from parent to daughter and/or from parent to son. Adjust-
ment for confounding or mediation was not relevant because the 
effect estimate represents an indirect effect between individuals 
rather than a direct or total causal effect within the individual (12). 
All analyses were performed using Stata MP, version 14.0.
RESULTS
The MUST study cohort was generally older, included a higher 
proportion of women, had attained a higher level of education, 
had higher body mass index levels, and had a lower proportion of 
smokers than the Nor- Twin study cohort (Table 1). The prevalence 






Age, mean ± SD years 63.9 ± 8.8 49.1 ± 10.9
Sex, female 437 (69.4) 4,034 (56.2)
College/university education 178 (28.3) 1,316 (18.3)
Body mass index, mean ± SD kg/m2 28.0 ± 4.8 22.6 ± 2.9
Current smoker 95 (15.2) 2,777 (38.7)
Offspring
Hip OA, ACR† 103 (16.4) –
Hip OA, surgery‡ 60 (9.5) 255 (3.6)
Knee OA, ACR† 116 (18.4) –
Knee OA, surgery‡ 48 (7.6) 133 (1.9)
Hand OA, ACR† 328 (52.1) –
Familial OA
Mothers with OA 235 (37.3) 767 (10.7)
Fathers with OA 83 (13.2) 320 (4.5)
Siblings with OA 148 (23.5) 140 (2.0)
* Except where indicated otherwise, values are the number (%). 
MUST = Musculoskeletal Pain in Ullensaker Study; Nor- Twin = Nor-
wegian Twin Osteoarthritis Study. 
† As defined in the American College of Rheumatology (ACR) criteria 
for the classification of osteoarthritis (OA). 
‡ Defined as a participant having had a total joint replacement due to 
primary OA in the left or right hip or knee. 
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of OA was higher in the MUST cohort, which was expected due 
to all participants having self- reported OA. However, upon clinical 
examination, 166 participants had no OA according to the ACR 
criteria or any OA- related surgery in any joint and were included 
in the disease- free control group. Disease- free controls in the 
Nor- Twin cohort had no self- reported OA (unspecified site) or sur-
gery due to hip or knee OA (n = 6,456). To evaluate the impact 
of selection of all persons self- reporting OA in the MUST cohort, 
we studied whether familial OA was associated with self- reported 
OA among offspring (nonspecific site) in the Nor- Twin OA cohort. 
In these analyses, maternal OA (RR 3.10 [95% CI 2.54–3.79]), 
paternal OA (RR 3.29 [95% CI 2.55–4.25]), and sibling OA (RR 
11.35 [95% CI 9.51–13.53]) increased the risk of self- reported OA 
by offspring.
Having a mother or a sibling with OA increased the risk of OA- 
related hip surgery by 44–56% in the MUST and Nor- Twin cohorts 
(Table 2). The most clearly elevated risk was observed for OA- related 
knee surgery in those with maternal OA, and for OA- related knee 
surgery, risk also increased (by 28–116%) in those with paternal OA 
(Table 2). However, for OA- related knee surgery, there was a differ-
ence in effect estimates as well as  precision for the MUST cohort 
versus the Nor- Twin cohort reported in Table 2, potentially due to 
fewer observations in the MUST study than in the Nor- Twin study.
Paternal OA consistently did not increase the risk of OA- 
related hip surgery (Table 2), and it also did not increase the risk 
of clinically defined knee, hip, or hand OA in offspring (Table 3). In 
contrast, maternal OA increased the risk of offspring clinical hip 
and hand OA by 21–38%, and sibling/twin OA increased the risk 
of offspring knee and hand OA by 26–44% (Table 3). Due to a low 
number of subjects, we did not attempt to study identical and 
fraternal twins separately.
With the generally consistent findings for maternal and 
paternal OA and the specific OA definitions, we grouped all 
types of OA together when analyzing the parent–daughter and 
Table 2. Familial recurrence of surgically defined OA in the MUST and the Nor- Twin cohorts*
Family  
relationship
Hip OA Knee OA
MUST Nor- Twin MUST Nor- Twin
Prevalence, 
no./total no. 
(%) RR (95% CI)
Prevalence, 
no./total no. 
(%) RR (95% CI)
Prevalence, 
no./total no. 
(%) RR (95% CI)
Prevalence, 
no./total no. 
(%) RR (95% CI)
Mother











With OA 25/71 (35.2) 1.56 
(1.02–2.40)
34/649 (5.2) 1.44 
(1.02–2.04)
24/70 (34.3) 2.06 
(1.26–3.35)
20/635 (3.2) 1.66 
(1.04–2.65)
Father









With OA 7/28 (25.0) 0.93 
(0.47–1.84)
10/263 (3.8) 1.00 
(0.54–1.86)
8/29 (27.5) 1.28 
(0.67–2.44)
11/264 (4.2) 2.16 
(1.18–3.95)
Siblings








33/172 (19.2) 1.00 (referent)
With OA 19/46 (41.3) 1.81 
(1.17–2.81)
10/66 (15.2) 4.11 
(2.29–7.37)
6/62 (9.7) 1.86 
(1.12–3.10)
15/42 (35.7) 4.97 
(2.28–10.85)
* RR = relative risk; 95% CI = 95% confidence interval (see Table 1 for other definitions). 
Table 3. Familial recurrence of clinically defined OA in the MUST trial*
Family relationship
Hip OA Knee OA Hand OA
Prevalence, 
no./total no. (%) RR (95% CI)
Prevalence, 
no./total no. (%) RR (95% CI)
Prevalence, 
no./total no. (%) RR (95% CI)
Mother
No OA 62/182 (34.1) 1.00 (referent) 72/192 (37.5) 1.00 (referent) 192/312 (61.5) 1.00 (referent)
With OA 41/87 (47.1) 1.38 (1.02–1.87) 44/90 (48.8) 1.30 (0.98–1.72) 136/182 (70.1) 1.21 (1.07–1.37)
Father
No OA 86/231 (37.2) 1.00 (referent) 98/243 (40.3) 1.00 (referent) 282/427 (66.0) 1.00 (referent)
With OA 17/38 (44.7) 1.20 (0.81–1.78) 18/39 (46.2) 1.14 (0.79–1.66) 46/67 (68.7) 1.04 (0.87–1.24)
Siblings
No OA 81/220 (36.8) 1.00 (referent) 84/223 (37.7) 1.00 (referent) 230/369 (62.3) 1.00 (referent)
With OA 22/49 (44.8) 1.22 (0.86–1.74) 32/59 (54.2) 1.44 (1.08–1.92) 98/125 (78.4) 1.26 (1.11–1.42)
* RR = relative risk; 95% CI = 95% confidence interval (see Table 1 for other definitions). 
MATERNAL AND PATERNAL EFFECTS ON OA |      1847
parent–son associations (surgical and clinical OA in any joint 
for the MUST cohort; surgical OA in any joint for the Nor- Twin 
cohort). Having a mother with OA consistently increased the 
risk of any OA in daughters (RR 1.13 [95% CI 1.02–1.25] in 
the MUST cohort; RR 1.44 [95% CI 1.05–1.97] in the Nor- Twin 
cohort), and (though with less certainty) in sons (RR 1.16 [95% 
CI 0.95–1.43] in the MUST cohort; RR 1.31 [95% CI 0.71–2.41] 
in the Nor- Twin cohort) (see Supplementary Table 1, available 
on the Arthritis & Rheumatology web site at http://onlin elibr ary.
wiley.com/doi/10.1002/art.41023/ abstract). In contrast, having 
a father with OA did not increase the risk of any OA in daugh-
ters (RR 1.00 [95% CI 0.85–1.16] in the MUST cohort; RR 1.52 
[95% CI 0.94–2.46] in the Nor- Twin cohort) or in sons (RR 1.08 
[95% CI 0.83–1.41] in the MUST cohort; RR 0.93 [95% CI 
0.35–2.48] in the Nor- Twin cohort) (Supplementary Table 1 at 
http://onlin elibr ary.wiley.com/doi/10.1002/art.41023/ abstract). 
These findings were confirmed in the MUST cohort for clinical 
OA of the hand, which was the most prevalent OA location/
definition in our study (Supplementary Table 2 at http://onlin e 
libr ary.wiley.com/doi/10.1002/art.41023/ abstract).
DISCUSSION
In our study of 2 population- based Norwegian cohorts, we 
found that moderate- to- severe OA at any site, as well as OA in 
the hip and hand joints in offspring, may be inherited from the 
mother rather than from the father. Maternal OA also consistently 
increased the risk of offspring knee OA, whereas risk estimates 
for knee OA in offspring with paternal OA were more inconclusive. 
Finally, we found that OA at any site may most likely be transmit-
ted to offspring if the offspring is a daughter.
Our findings shed new light on previous studies of familial 
OA clustering. We showed for the first time that OA is more 
common in individuals with a mother affected with OA than in 
individuals with a father affected with OA. We also confirmed 
results of previous studies of sibling OA, showing that OA of 
the hips, OA of the knees, and OA of the hands are largely 
familial traits (3,13). These associations are likely due to com-
mon maternal influence (because there is no transfer of genes 
between siblings) rather than paternal influence. Similar to our 
findings, Jonsson et  al reported a high relative risk of inter-
phalangeal OA in the offspring of mothers with OA (13). We 
expanded on this knowledge by additionally studying paternal 
OA and including OA at other joint sites. However, we were 
unable to study different joint sites in hand OA because of 
challenges in finding a sufficiently large comparison group with 
no OA in the MUST cohort. Still, our analysis of offspring sex 
indicated that any OA and hand OA may be more likely to be 
inherited from the mother if the offspring is female, which sug-
gests an important direction for future research.
Our findings imply that there may be differences in maternal 
and paternal inheritance depending on joint site and grade of OA 
severity. As an example, we could not conclude as to whether 
paternal OA increases offspring’s knee OA risk. For OA- related 
knee surgery, the 95% CI of the risk associated with paternal OA 
in the Nor- Twin cohort was 18–395%, yet the 95% CI in the MUST 
cohort included a decreased risk of up to 33%. Further, effect 
estimates were also lower for clinical knee OA, in relation to both 
maternal and paternal OA. Our findings might be due to true diver-
sity and/or the number of samples being too small to observe a 
sufficient number of fathers with OA. We believe future studies 
should further explore the role of paternal inheritance, particularly 
in knee OA, on daughters and sons.
In our study, the disease- free comparison group was selected 
to be as similar as possible across all OA sites, avoiding the pos-
sibility that persons with OA at sites other than the site in ques-
tion would falsely deflate the RR of offspring OA. Hence, the 
disease-free comparison group was not allowed to have individ-
uals with clinical or surgical OA at the site in question or at any 
other site. However, in accordance with existing knowledge that 
OA often presents as a generalized disease (11), we allowed the 
inclusion of offspring with OA who also had OA at other sites, but 
not with definitions other than the definition in question. Despite 
our attempt to minimize bias, we cannot exclude the possibility 
that the selection of persons who self- reported OA impacted our 
findings in the MUST cohort. However, because of the strong 
associations between maternal, paternal, and sibling OA and self- 
reported OA (nonspecific site) in the offspring in the Nor- Twin study 
(RR 3.10–11.35), we believe any selection bias in the MUST cohort 
has likely led to an underestimation, rather than overestimation, of 
familial effects.
The current findings have implications for future studies of 
risk counseling and the etiology of OA. First, our results suggest a 
stronger role of genetic inheritance from the mother than the father 
in OA etiology. Future research on OA etiology may therefore 
explore the role of maternal- specific factors, such as the intrauter-
ine environment or mitochondrial DNA (14). Another possibility is 
the direct inheritance of OA genes or genotypes from the mother 
only (potentially related to female reproductive hormones) as we 
could confirm OA inheritance from mother to daughter but with 
less certainty from mother to son. We acknowledge, though, that 
the lower certainty for sons might be due to inclusion of fewer men 
with OA. Second, our findings may improve the prediction of future 
OA outcomes. In existing prediction models of knee OA, familial 
OA in general is included as a predictor (i.e., without specification 
of maternal, paternal, or sibling OA and without specification on 
offspring sex) (4). Future prediction studies may explore whether a 
more precise prediction can be made when familial OA is specified 
by family member for women versus men. Future studies may also 
further explore the maternal and paternal effects on early and mild 
OA disease stages, i.e., those involving structural joint features or 
joint pain only (15).
This study has some potential limitations. In the Nor- Twin 
cohort, clinical joint examination was not performed, and other 
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information not obtained, on nontwin siblings. Indeed, for surgical 
hip and knee OA, the RR of OA in subjects who had a twin with OA 
(Nor- Twin cohort) was higher than the RR of OA in subjects who had 
a sibling with OA (MUST cohort) (Table 2), which may be due to the 
stronger genetic and environmental link present between twins than 
between siblings. We included siblings/twins only to attenuate the 
comparison to existing studies on heritability and familial aggrega-
tion (1,3). Another limitation may be the stricter definition for clinical 
OA of the hip than for the knee, as we required more morphologic 
changes for the hip joint than for the knee joint; this may have led to 
the estimates for clinical hip OA yielding more severe OA whereas 
the estimates for clinical knee OA yielded milder OA. The last lim-
itation is the inability to distinguish between different locations and 
severities of OA in family members. For example, it may be hypoth-
esized that maternal hand OA increases the risk of offspring hand 
OA, but not of offspring hip or knee OA. However, we believe that 
such detailed parental data would be largely affected by recall bias 
if obtained from the offspring. A benefit of using the simple question 
on familial OA in the 2 cohorts studied is the ease of translation to 
the clinical setting.
In conclusion, we showed that there is a higher risk of mod-
erate and severe OA in offspring when the mother had OA than 
when the father had OA and/or when no close family members 
had OA. Maternal inheritance may be of particular relevance if 
the offspring is a daughter. Future studies may reveal the mech-
anism for this heritability since a limited number of chromosomes 
and DNA are involved in OA etiology.
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